Skip to content
Screener

Sarepta Therapeutics, Inc. SRPT Share Based Compensation Expense Included In Costs And Expenses

Share Based Compensation Expense Included In Costs And Expenses at other companies

EPR Properties logo
EPR PropertiesEPR
$1.04M
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$12.7M-28.2%
VeriSign logo
VeriSignVRSN
$19.7M+21.6%
American Well logo
American WellAMWL
$2.3M-70.0%
JPMorgan Chase logo
JPMorgan ChaseJPM
$1.17B+21.7%
Accenture logo
AccentureACN
$462.14M-7.2%

Other financials

Income statement

See full
Revenue$401.3M-34.3%
Operating income$13.3M-88.5%
Net income-$4.9M-102%
EPS (diluted)-$0.05-103%

Balance sheet

See full
Cash & equivalents$571.1M+11.9%
Total debt$198.2M-7.6%
Total equity$1.5B+8.8%
Total assets$3.2B-13.4%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$555.0K-98.3%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.68B+5.2%
Enterprise value$1.31B+0.5%
P/S0.9×

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin-6.9%
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-9.3%+2,662pp
Debt / equity0.1×0.0×
Current ratio4.4×+1.5×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:ShareBasedCompensationExpenseIncludedInCostsAndExpenses.

The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:01 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335003
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Restricted and performance stock units23,05228,11449,62959,657
Employee stock purchase plan1,8153,939
Subtotal$28,030$41,618$61,703$88,174
Capitalized stock-based compensation costs(3,558)(4,593)(7,832)(9,721)
Total stock-based compensation expense included in expenses$24,472$37,025$53,871$78,453
Research and development8,50915,27718,78632,594
Selling, general and administrative15,96321,74835,08545,859
Total stock-based compensation expense included in expenses$24,472$37,025$53,871$78,453

Item 1. Financial Statements

FAQ

What is Sarepta Therapeutics, Inc.'s share based compensation expense included in costs and expenses?
Sarepta Therapeutics, Inc. (SRPT) reported share based compensation expense included in costs and expenses of $24.47M in Q2 2026.
How has Sarepta Therapeutics, Inc.'s share based compensation expense included in costs and expenses changed year-over-year?
Sarepta Therapeutics, Inc.'s share based compensation expense included in costs and expenses decreased by 33.9% year-over-year, from $37.03M to $24.47M.
What does share based compensation expense included in costs and expenses mean?
Share Based Compensation Expense Included In Costs And Expenses as reported by Sarepta Therapeutics,, Inc. Common Stock.

Ask your AI about Sarepta Therapeutics, Inc.'s share based compensation expense included in costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude